Chemsex, HIV Risk Require Tailored Harm Reduction Strategies
The complex association between chemsex — a form of sexualized drug use that includes elements of planning and a clear intent to use specific drugs to enhance the sexual experience — and HIV among gay, bisexual, and other men who have sex with men (GBMSM) requires deeper understanding and integrated interventions.Source: Medscape
Addressing the Intertwined Opioid, HIV, and HCV Crises: Q&A With Rick Altice
Frederick Altice, MD, has brought together team members from both Yale and West Virginia University to implement integrated care to take steps to curb the intertwined and devastating epidemics of opioid abuse, HIV, and hepatitis C.
Yale Community Health Care Van vaccinates underserved populations, religious communities
As students and New Haven residents scramble to book COVID-19 vaccine appointments, one 40-foot-long van and a team of health care workers are driving vaccine accessibility in underserved populations.Source: Yale Daily News
Yale Community Health Care Van Takes to the Street to Vaccinate Hard-to-Reach New Haven Residents
“It’s about keeping people safe,” said Dr. Frederick Altice, a Yale School of Medicine professor who specializes in infectious diseases and epidemiology and is the creator of the Community Health Care Van program.Source: New Haven Register
A Gift for The Community Health Care Van
On Friday, February 12, the New England Chapter of the March of Dimes (MOD) and the Real Estate Foundation collectively delivered a $30,000 check to Yale School of Medicine’s Community Healthcare Van’s Mobile Health Unit. March of Dimes also secured a $30,000 matching gift from its partner Anthem, totaling $60,000 to help the Mobile Health Unit expand its capacity.
Release Connecticut’s Prisoners? Health Experts, Activists Urge “Decarceration” to Slow Pandemic
Members of the Yale and local activist communities are coming together to urge Connecticut Gov. Ned Lamont to depopulate the state’s prisons to combat the spread of COVID-19 and protect the state’s most vulnerable populations from the pandemic.
Low HIV transmission among recently incarcerated individuals living with HIV and SUDs
An assessment of sexual risk behaviors, as they relate to viral suppression, from before, during and after incarceration among persons living with HIV and alcohol use or opioid use disorders demonstrated that the risk of HIV transmission among this population is low.Source: Healio
$5.5 Million Grant Supports Study of Model to Integrate Treatments for Opioid Addiction, Infectious Diseases
As part of a multi-site collaboration involving principal investigators from Columbia University, Medical University of South Carolina (MUSC), and University of South Carolina School of Medicine-Greenville, Yale’s Dr. Sandra Springer will study a new model of treatment for opioid addiction. The investigation is supported by a grant from the National Center for Advancing Translational Sciences.
Opioid Use Disorder Should Be Thought of Like an Infectious Disease, Experts Say
Opioid use disorder (OUD) is not an infectious disease, but a new paper from the National Institutes of Health (NIH) and the University of Maryland argues that ID specialists need to start considering themselves as a first line of treatment against the disorder.Source: Contagion Live
After Prison, Many People Living With HIV Go Without Treatment
When people living with HIV walk out of prison, they leave with up to a month's worth of HIV medication in their pockets. What they don't necessarily leave with is access to health care or the services that will keep them healthy in the long term.Source: NPR
High rates of HIV and diabetes raise the risk of TB for South Africans
Since the 1980s, HIV has contributed to an increase in tuberculosis (TB) cases across the globe. Recently, diabetes has been found to be an important risk factor for TB. In a new study, Yale researchers investigated whether having both HIV and diabetes increases the risk of developing TB among individuals living in rural South Africa.
Hepatitis C ‘treatment as prevention’ strategy examined in new study
Hepatitis C infection is a global phenomenon that affects millions worldwide, with an estimated 30,500 new cases in the United States alone each year. Expanding treatment, however, could go a long way toward preventing transmission of the virus among high-risk individuals who inject drugs, according to new Yale-led research.